一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Circulatory system drugs>Antihypertensive drugs>Hydralazine hydrochloride
Hydralazine hydrochloride
  • Hydralazine hydrochloride

Hydralazine hydrochloride NEW

Price $36 $73
Package 200mg 500mg
Supply Ability: 10g
Update Time: 2026-04-22

Product Details

Product Name: Hydralazine hydrochloride CAS No.: 304-20-1
Purity: 99.86% Supply Ability: 10g
Release date: 2026/04/22

Product Introduction

Bioactivity

NameHydralazine hydrochloride
DescriptionHydralazine hydrochloride (Apresoline) is the hydrochloride salt of hydralazine, a phthalazine derivative with antihypertensive and potential antineoplastic activities. Hydralazine alters intracellular calcium release and interferes with smooth muscle cell calcium influx, resulting in arterial vasodilatation. This agent also inhibits the phosphorylation of myosin protein and chelation of trace metals required for smooth muscle contraction, resulting in an increase in heart rate, stroke volume, and cardiac output. In addition to its cardiovascular effects, hydralazine inhibits DNA methyltransferase, which may result in inhibition of DNA methylation in tumor cells.
In vitroHydralazine impairs up-regulation of RAG-2 gene expression and reduces secondary Ig gene rearrangements. Hydralazine subverts B lymphocyte tolerance to self and contributes to generation of pathogenic autoreactivity by disrupting receptor editing. [1] Hydralazine directly scavenges free acrolein, decreasing intracellular acrolein availability and thereby suppressing macromolecular adduction. Hydralazine inhibits cross-linking if adding 30 min after commencing acrolein exposure but is ineffective if added after a 90-min delay. [2] Hydralazine (0.1-10 mM) inhibits both extracellular and intracellular ROS production by inflammatory macrophages, by a ROS-scavenging mechanism probably affecting superoxide radical (O(2)(*-))-generation by xanthine oxidase (XO) and nicotinamide adenine dinucleotide/nicotinamide adenine dinucleotide phosphate (NADH/NADPH) oxidase. Hydralazine (0.1-10 mM) significantly reduces NO(*) generation, and this effect is attributable to an inhibition of NOS-2 gene expression and protein synthesis. Hydralazine also effectively blocks COX-2 gene expression which perfectly correlated with a reduction of protein levels and PGE(2) synthesis. [3] Hydralazine protects against not only acrolein-mediated injury, but also compression in guinea pig spinal cord ex vivo. Hydralazine can significantly alleviate acrolein-induced superoxide production, glutathione depletion, mitochondrial dysfunction, loss of membrane integrity, and reduces compound action potential conduction. [4]
In vivoHydralazine affords strong, dose-dependent protection against the increases in plasma marker enzymes but not the hepatic glutathione depletion produced by allyl alcohol in mice. [5]
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationH2O : 20 mg/mL (101.71 mM), Sonication is recommended.
DMSO : Insoluble
Keywordsorally active | MAO | Inhibitor | inhibit | Hypoxia-inducible factors | Hydralazine Hydrochloride | Hydralazine | HIFs | HIFProlylHydroxylase | HIF-PH | HIF/HIFProlylHydroxylase | HIF/HIF Prolyl-Hydroxylase | HIF/HIF ProlylHydroxylase | HIF Prolyl-Hydroxylase | HIF ProlylHydroxylase | HIF | arterial vessel | antihypertensive
Inhibitors RelatedStavudine | Aceglutamide | Urea | Tamoxifen | Cysteamine hydrochloride | Metronidazole | Citric Acid Triammonium | Formamide | Paeonol | Dimethyl phthalate | Alginic acid | Sildenafil citrate
Related Compound LibrariesBioactive Compound Library | ReFRAME Related Library | Toxic Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Orally Active Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
VIP6Y
WUHAN FORTUNA CHEMICAL CO., LTD
2026-07-07
VIP2Y
Shaanxi Dideu New Materials Co. Ltd
2026-06-30
$10.00
Hebei Chuanghai Biotechnology Co., Ltd
2026-03-20
$30.00
Anhui Ruihan Technology Co., Ltd
2023-09-07
$15.00
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-13
VIP7Y
Shaanxi Dideu Medichem Co. Ltd
2020-05-10
$7.00
VIP8Y
Career Henan Chemical Co
2019-07-06
$15.00
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-09
$15.00
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-02

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY
潜江市| 鄢陵县| 依安县| 牙克石市| 乌兰县| 长垣县| 从江县| 云林县| 平远县| 怀仁县| 珲春市| 泗水县| 尼勒克县| 横峰县| 铜山县| 壤塘县| 郧西县| 弋阳县| 江永县| 宁武县| 洪泽县| 余干县| 长春市| 封开县| 岳池县| 武胜县| 玉门市| 扎鲁特旗| 台州市| 凤山县| 恩平市| 电白县| 天等县| 普格县| 噶尔县| 柯坪县| 胶州市| 黎城县| 沙田区| 信丰县| 黑河市|